ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being recalled due to the presence of an impurity,
N-nitrosodiethylamine (NDEA) contained in the API Irbesartan, USP manufactured by Aurobindo Pharma Limited. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a...

Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartan
due to the presence of an impurity, N-nitrosodiethylamine (NDEA). The impurity, which is a
substance that occurs naturally in certain foods, drinking water, air pollution, and industrial
processes, has been classified as a probable human carcinogen as per International Agency for
Research on Cancer (IARC).